COUNCIL FOR RESPONSIBLE NUTRITION — Lobbying Disclosure | Poliscope

COUNCIL FOR RESPONSIBLE NUTRITION

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$9.5M

Filings

200

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$240,000	3	1
2025	$350,000	7	2
2024	$340,000	8	2
2023	$330,000	8	2
2022	$390,000	10	2
2021	$240,000	8	2
2020	$270,000	8	2
2019	$610,000	10	2
2018	$570,000	12	3
2017	$650,000	10	2
2016	$370,000	8	2
2015	$380,000	8	2
2014	$390,000	12	3
2013	$410,000	12	3
2012	$520,000	12	3
2011	$530,000	11	3
2010	$520,000	8	2
2009	$470,000	8	2
2008	$480,000	8	2
2007	$400,000	4	2
2006	$180,000	2	2
2005	$120,000	3	2
2004	$360,000	5	3
2003	$60,000	3	2
2002	$120,000	2	1
2001	—	2	1
2000	$20,000	3	2
1999	$200,000	5	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
COUNCIL FOR RESPONSIBLE NUTRITION	$9,520,000	95
ALPINE GROUP PARTNERS, LLC.	—	77
MCGUINESS & HOLCH	—	6
BERGNER BOCKORNY CASTAGNETTI HAWKINS & BRAIN	—	3
DENTONS US LLP	—	4
FIDELIS GOVERNMENT RELATIONS	—	15

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	185
SENATE	185
Food & Drug Administration (FDA)	78
Health & Human Services, Dept of (HHS)	14
Treasury, Dept of	10
Agriculture, Dept of (USDA)	9
Commerce, Dept of (DOC)	9
U.S. Trade Representative (USTR)	6
Drug Enforcement Administration (DEA)	5
Federal Trade Commission (FTC)	4
Homeland Security, Dept of (DHS)	2
Internal Revenue Service (IRS)	2
Natl Institutes of Health (NIH)	2
Office of Management & Budget (OMB)	2
Consumer Product Safety Commission (CPSC)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	106
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	101
Health Issues	Health Issues	71
Budget/Appropriations	Budget/Appropriations	43
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	36
Defense	Defense	24
Agriculture	Agriculture	20
Trade (domestic/foreign)	Trade (domestic/foreign)	15
Natural Resources	Natural Resources	4
Alcohol and Drug Abuse	Alcohol and Drug Abuse	4
Environment/Superfund	Environment/Superfund	3
Economics/Economic Development	Economics/Economic Development	2
Homeland Security	Homeland Security	2
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	2
Education	Education	1
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 10336119th Congress

Dietary Supplement Innovation Act

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's "Simple Reform" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 10336

H.R. 7366119th Congress

Dietary Supplement Regulatory Uniformity Act

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's "Simple Reform" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 7366

H.R. 7502119th Congress

Recycled Materials Attribution Act of 2026

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.

Client expense: $70,000 · Firm income: —

Matched citations: H.R.7502

H.R. 8370119th Congress

Dietary Supplement Listing Act of 2026

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's "Simple Reform" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 8370

Show 21 more cited filings

H.R. 8933119th Congress

Dietary Supplements Access Act

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 8933

H.R. 8962119th Congress

PERFECT Act of 2026

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Monitored any issues related to the dietary supplements industry, including H.R.8962, The PERFECT Act of 2026.

Client expense: $70,000 · Firm income: —

Matched citations: H.R.8962

S. 3677119th Congress

Dietary Supplement Listing Act of 2026

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's "Simple Reform" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: —

Matched citations: S. 3677

S. 4587119th Congress

Dietary Supplements Access Act

2026 · third_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).

Client expense: $70,000 · Firm income: —

Matched citations: S. 4587

H.R. 7366119th Congress

Dietary Supplement Regulatory Uniformity Act

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. General issues related to the dietary supplement industry.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 7366

H.R. 7502119th Congress

Recycled Materials Attribution Act of 2026

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.

Client expense: $100,000 · Firm income: —

Matched citations: H.R.7502

H.R. 8370119th Congress

Dietary Supplement Listing Act of 2026

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. General issues related to the dietary supplement industry.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 8370

H.R. 8933119th Congress

Dietary Supplements Access Act

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 8933

H.R. 8962119th Congress

PERFECT Act of 2026

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Monitored any issues related to the dietary supplements industry, including H.R.8962, The PERFECT Act of 2026.

Client expense: $100,000 · Firm income: —

Matched citations: H.R.8962

S. 3677119th Congress

Dietary Supplement Listing Act of 2026

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. General issues related to the dietary supplement industry.

Client expense: $100,000 · Firm income: —

Matched citations: S. 3677

S. 4587119th Congress

Dietary Supplements Access Act

2026 · second_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).

Client expense: $100,000 · Firm income: —

Matched citations: S. 4587

H.R. 7366119th Congress

Dietary Supplement Regulatory Uniformity Act

2026 · first_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Mandatory product listing requirements for dietary supplements, including policy issues related to S. 3677, the Dietary Supplement Listing Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 7366

H.R. 7502119th Congress

Recycled Materials Attribution Act of 2026

2026 · first_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.

Client expense: $70,000 · Firm income: —

Matched citations: H.R.7502

S. 3677119th Congress

Dietary Supplement Listing Act of 2026

2026 · first_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Mandatory product listing requirements for dietary supplements, including policy issues related to S. 3677, the Dietary Supplement Listing Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: —

Matched citations: S. 3677

S. 1158118th Congress

Health Savings Act of 2023

2025 · first_quarter · Firm: ALPINE GROUP PARTNERS, LLC.

Open original LDA filing ↗

Cited source text and reported amounts

S. 1158, Health Savings Act of 2023

Client expense: — · Firm income: $50,000

Matched citations: S. 1158

H.R. 1628118th Congress

CBD Product Safety and Standardization Act of 2023

2024 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to dietary supplements H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R.1628 CBD Product Safety and Standardization Act of 2023 H.R.4794 Dietary Supplements Access Act Mandatory Product Listing

Client expense: — · Firm income: $50,000

Matched citations: H.R.1628

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to dietary supplements H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R.1628 CBD Product Safety and Standardization Act of 2023 H.R.4794 Dietary Supplements Access Act Mandatory Product Listing

Client expense: — · Firm income: $50,000

Matched citations: H.R.1629

H.R. 4794118th Congress

Dietary Supplements Access Act

2024 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.

Open original LDA filing ↗

Cited source text and reported amounts

S. 1158, Health Savings Act of 2023 H.R. 4794 Dietary Supplements Access Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 4794

H.R. 4794118th Congress

Dietary Supplements Access Act

2024 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to dietary supplements H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R.1628 CBD Product Safety and Standardization Act of 2023 H.R.4794 Dietary Supplements Access Act Mandatory Product Listing

Client expense: — · Firm income: $50,000

Matched citations: H.R.4794

S. 1158118th Congress

Health Savings Act of 2023

2024 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.

Open original LDA filing ↗

Cited source text and reported amounts

S. 1158, Health Savings Act of 2023 H.R. 4794 Dietary Supplements Access Act

Client expense: — · Firm income: $50,000

Matched citations: S. 1158

H.R. 1629118th Congress

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

2024 · fourth_quarter · Firm: COUNCIL FOR RESPONSIBLE NUTRITION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory Product Listing for dietary supplements. General issues related to the dietary supplements industry.

Client expense: $90,000 · Firm income: —

Matched citations: H.R. 1629

Source: Senate LDA